Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the detailed record of transactions filed by Pfeiffenberger Brent. Director active across 3 companies, notably Century Therapeutics, Inc.. Aggregated, 22 disclosures have been recorded. Split: 2 buys · 6 sells. Total volume traded: €96k. History available since 4 December 2023. The latest transaction was disclosed on 14 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Pfeiffenberger Brent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Pfeiffenberger Brent is an executive at Century Therapeutics, Inc., where he is President and CEO, at Corbus Pharmaceuticals Holdings, Inc., where he is a Director, and at Butterfly Network, Inc., where he is President and CEO. He has 21 filings in total, and across the 21 sampled recent filings, the buy and sell amounts are EUR 40818 and EUR 54755, with filings ranging from 2023-12-06 to 2026-06-15.